Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Pharmacol Ther ; 99(2): 214-23, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26259627

RESUMO

Drug-induced long QT syndrome has resulted in many drugs being withdrawn from the market. At the same time, the current regulatory paradigm for screening new drugs causing long QT syndrome is preventing drugs from reaching the market, sometimes inappropriately. In this study, we report the results of a first-of-a-kind clinical trial studying late sodium (mexiletine and lidocaine) and calcium (diltiazem) current blocking drugs to counteract the effects of hERG potassium channel blocking drugs (dofetilide and moxifloxacin). We demonstrate that both mexiletine and lidocaine substantially reduce heart-rate corrected QT (QTc) prolongation from dofetilide by 20 ms. Furthermore, all QTc shortening occurs in the heart-rate corrected J-Tpeak (J-Tpeak c) interval, the biomarker we identified as a sign of late sodium current block. This clinical trial demonstrates that late sodium blocking drugs can substantially reduce QTc prolongation from hERG potassium channel block and assessment of J-Tpeak c may add value beyond only assessing QTc.


Assuntos
Antiarrítmicos/uso terapêutico , Síndrome do QT Longo/induzido quimicamente , Síndrome do QT Longo/tratamento farmacológico , Bloqueadores dos Canais de Sódio/efeitos adversos , Adulto , Antiarrítmicos/farmacocinética , Bloqueadores dos Canais de Cálcio/farmacocinética , Bloqueadores dos Canais de Cálcio/uso terapêutico , Estudos Cross-Over , Diltiazem/farmacocinética , Diltiazem/uso terapêutico , Quimioterapia Combinada , Eletrocardiografia/efeitos dos fármacos , Canais de Potássio Éter-A-Go-Go/antagonistas & inibidores , Feminino , Fluoroquinolonas/efeitos adversos , Frequência Cardíaca/efeitos dos fármacos , Humanos , Lidocaína/farmacocinética , Lidocaína/uso terapêutico , Masculino , Mexiletina/farmacocinética , Mexiletina/uso terapêutico , Moxifloxacina , Fenetilaminas/efeitos adversos , Estudos Prospectivos , Sulfonamidas/efeitos adversos , Adulto Jovem
2.
J Microsc ; 213(1): 70-5, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14678514

RESUMO

A fluctuation analysis was performed on the reduced nicotine adenine dinucleotide (NADH) fluorescence signal from resting rabbit myocytes using confocal and two-photon microscopy. The purpose of this study was to establish whether any co-ordinated biochemical processes, such as binding, metabolism and inner mitochondrial membrane potential, were contributing to NADH signal fluctuations above background instrument noise. After a basic characterization of the instrument noise, time series of cellular NADH fluorescence images were collected and compared with an internal standard composed of NADH in the bathing medium. The coefficient of variation as a function of mean signal amplitude of cellular NADH fluorescence and bathing media NADH was identical even as a function of temperature. These data suggest that the fluctuations in cellular NADH fluorescence in resting myocytes are dominated by sampling noise of these instruments and not significantly modified by biological processes. Further analysis revealed no significant spatial correlations within the cell, and Fourier analysis revealed no coherent frequency information. These data suggest that the impact of biochemical processes, which might affect cellular NADH fluorescence emission, are either too small in magnitude, occurring in the wrong temporal scale or too highly spatially localized for detection using these standard optical microscopy approaches.


Assuntos
Fluorescência , Mitocôndrias Cardíacas/metabolismo , Miócitos Cardíacos/metabolismo , NAD/metabolismo , Animais , Processamento de Imagem Assistida por Computador , Microscopia Confocal/métodos , Microscopia de Fluorescência/métodos , Fótons , Coelhos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...